Access SARS-CoV-2 IgM Antibody Test by Beckman Coulter

Manufacturer Beckman Coulter
5.0
/
5.0
  |  2 reviews

By integrating a high-quality set of SARS-CoV-2-specific antibody tests into their routine workflow, laboratories of all sizes can give physicians greater clarity on patient immune response to the virus that causes COVID-19.


Access SARS-CoV-2 IgM Antibody Test by Beckman Coulter product image
Access SARS-CoV-2 IgM Antibody Test

The supplier does not provide quotations for this particular product through SelectScience. You can search for similar products in our product directory.




Average Rating: 5.0
2 Scientists have reviewed this product

5 out of 5
Ease of use
5 out of 5
After sales service
5 out of 5
Value for money


  • Status:

    Reviewer
  • Member since: 2021

  • Organization: KPG Automation



  • Ease of use
    5 out of 5
    After sales service
    5 out of 5
    Value for money
    5 out of 5
Share this Review on LinkedinShare this Review on TwitterShare this Review on Facebook
Great assay.
Rating: 5.0

  • Application Area: Coronavirus assay

"Access SARS-CoV-2 IgM assay played a big role of identifying patients with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection by corona. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity, so it was a very effective assay with coronavirus patients in our region. "

Review date: 26 May 2021 | Access SARS-CoV-2 IgM Antibody Test
  • Status:

    Reviewer

  • Member since: 2021

  • Organization: CRUK-TDL



  • Ease of use
    5 out of 5
    After sales service
    5 out of 5
    Value for money
    5 out of 5
Share this ReviewShare this Review on TwitterShare this Review
Tests are reliable and repeated. Very good quality.
Rating: 5.0

  • Application Area:Cancer research

"The Access SARS-CoV2 IgM product by Beckman Coulter was very well received by customers. The value for money rating is very good. Tests are reliable and repeated. No reservations as to the quality and ease of performing the test."

Review date: 26 May 2021 | Access SARS-CoV-2 IgM Antibody Test

The Case for Separate Tests

When a total IgG and IgM assay is positive, it is unclear if the patient is currently infected or has an immune response to a prior infection.

This is because developed IgM is not sustained, while developed IgG can potentially be sustained longer, depending upon the infection and the individual.

In various studies, it has been seen that seroconversion for SARS-CoV-2 IgG and IgM may occur simultaneously or sequentially1. Thus, it’s important to identify both IgG and IgM individually. An IgM assay may provide information about current or recent infection; while IgG may signal a more sustained immune response.

A Menu that Matters

By integrating high-quality antibody tests into a routine workflow, laboratories of all sizes can offer physicians a set of tools to gain greater clarity on individuals who have antibodies to SARS-CoV-2 due to prior or recent viral infection.

High Sensitivity and Specificity

High sensitivity and specificity are key to providing physicians an accurate picture of patient immune response. Both the Access SARS-CoV-2 IgM and Access SARS-CoV-2 IgG tests have been validated against large, broad-based samples to ensure high quality.

Seamless Integration with Routine Lab Workflow

The Access SARS-CoV-2 IgM assay can be seamlessly integrated into current laboratory workflow without the need for batching or special maintenance. This can help your laboratory experience industry-leading system uptime.